paroxetine has been researched along with Tremor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Henderson, TT; Kavanagh, JJ; Morrison, S; Thorstensen, JR; Tucker, MG | 1 |
| John, P; McConnell, K; Saif, MW | 1 |
| Lai, H; Tolat, R | 1 |
| Debattista, C; Schatzberg, AF | 1 |
| Bray, J; Hunter, BN; Judge, R; Morton, NH; Ravindran, AV | 1 |
| Bauer, M; Jobert, M; Müller-Oerlinghausen, B; Zaninelli, R | 1 |
| Andersson, K; Bertilsson, L; Härtter, S; Laine, K; Svensson, JO; Tybring, G; Widén, J | 1 |
1 review(s) available for paroxetine and Tremor
| Article | Year |
|---|---|
Paroxetine-related tremor.
Topics: Aged; Aged, 80 and over; Contraindications; Depressive Disorder; Female; Geriatrics; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tremor | 2005 |
3 trial(s) available for paroxetine and Tremor
| Article | Year |
|---|---|
A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Clomipramine; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Headache; Humans; Middle Aged; Nausea; Paroxetine; Patient Dropouts; Placebos; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Tremor; Xerostomia | 1997 |
Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antimanic Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Male; Middle Aged; Paroxetine; Statistics, Nonparametric; Tremor | 2001 |
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Topics: Adult; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Mixed Function Oxygenases; Nortriptyline; Paroxetine; Phenotype; Tremor; Xerostomia | 2001 |
3 other study(ies) available for paroxetine and Tremor
| Article | Year |
|---|---|
Physiological tremor is suppressed and force steadiness is enhanced with increased availability of serotonin regardless of muscle fatigue.
Topics: Adult; Biomechanical Phenomena; Elbow; Humans; Isometric Contraction; Male; Muscle Fatigue; Muscle, Skeletal; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tremor; Young Adult | 2022 |
Chin tremors associated with paroxetine in a patient with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Anxiety; Chemotherapy, Adjuvant; Chin; Deoxycytidine; Female; Gemcitabine; Humans; Pancreatic Neoplasms; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tremor; Withholding Treatment | 2013 |
Physical symptoms associated with paroxetine withdrawal.
Topics: Adult; Depressive Disorder; Dizziness; Ejaculation; Fatigue; Humans; Male; Middle Aged; Nausea; Paroxetine; Substance Withdrawal Syndrome; Tremor | 1995 |